DOSSIER · UPDATED 18 NOV 2025

RosVivo Therapeutics

RosVivo Therapeutics is a biotechnology company it develops microRNA-based therapeutics for type 2 diabetes, obesity, fatty liver disease. RosVivo Therapeutics targets diseases with breakthrough therapies utilizing microRNA (miRNA) and…

rosvivo.com ↗Claim this profile

Founded: 2021
Headcount: 9
Open roles: 0
Last raised: Total · $5M

SECTION I · THE BRIEF

Inside RosVivo Therapeutics

Brief #61664Updated 18 NOV 2025RENOMEDICAL ORGANIZATIONS

Employbl Dossier

RosVivo Therapeutics

Founded: 2021
Headcount: 9
Open roles: 0
Last raised: Total · $5M

Section II · Premium ProfileMembers only

01Engineering interview process at RosVivo TherapeuticsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open RosVivo Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Seungil Ro

Molecular biology researcher

RosVivo TherapeuticsUniversity of Nevada School of MedicineUniveristy fo Nevada School of MedicineUniversity of Nevada Las Vegas (UNLV)University of Nevada RenoUniversity of Nevada RenoCalifornia State University Sacramento원광대학교(Wonkwang University)